Author

Concetta Quintarelli

Bambino Gesù Children's HospitalORCID 0000-0002-4343-9705Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alessandro Sparaci· 1 shared Anaïs Vermare· 1 shared Andrea ValentiniiD· 1 shared Antonio NovelliiD· 1 shared Biagio De AngelisiD· 1 shared Bianca Laura CinicolaiD· 1 shared Camille Combe· 1 shared Chiara Sugoni· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alessandro Sparaci

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 15, 2026

Systemic-to-mucosal trafficking of memory B cells contributes to humoral immunity in the upper respiratory tract

Eva Piano Mortari, Mattia Laffranchi, Bianca Laura Cinicola…·Rita Carsetti

The paper shows that systemic memory B cells traffic to mucosal sites in the upper respiratory tract, contributing to local immunity, and that antigen-specific B cells accumulate there only during local inflammation.

DOI 10.64898/2026.04.17.719191

humanflow cytometry

𝕏 PostBluesky

ImmunologyMolecular TherapyPeer-reviewedApr 4, 2026

An in vivo CRISPR screen unveils top target genes to improve CAR-T cell efficacy in a solid tumor model

Mattia Fumagalli, Dongjie An, Luca Simula…·Frédéric Pendino

This study uses an in vivo CRISPR screen to identify genes that enhance CAR-T cell efficacy in a solid tumor model, finding that disrupting REGNASE-1, SOCS1, PTPN2, and P16/NK4A improves tumor eradication.

4 citationstop 1%

humangenetic perturbation / CRISPR

𝕏 PostBluesky